Identifying specific patterns of lncRNA-PI3K/AKT pathway interactions in gastrointestinal tumors not only lays a theoretical foundation for related therapeutic avenues but also aids in discovering valuable biomarkers for disease progression and prognosis. Here, PIK3CB is linked to digestive system neoplasm.